Novel biomarkers are critical because they can improve the early detection of cancer, enhance the accuracy of diagnosis, and offer targets for new therapies. They also hold the potential to personalize cancer treatment, leading to better outcomes for patients. Traditional biomarkers have limitations, and novel biomarkers can provide more specific, sensitive, and reliable information.
